Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Effects of echinocandins on cytokine/chemokine production by human monocytes activated by infection with Candida glabrata or by lipopolysaccharide.

Baltch AL, Lawrence DA, Ritz WJ, Andersen NJ, Bopp LH, Michelsen PB, Carlyn CJ, Smith RP.

Diagn Microbiol Infect Dis. 2012 Mar;72(3):226-33. doi: 10.1016/j.diagmicrobio.2011.11.004. Epub 2011 Dec 29.

PMID:
22209510
2.

Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide.

Baltch AL, Lawrence D, Ritz WJ, Andersen N, Bopp LH, Michelsen PB, Carlyn CJ, Smith RP.

Chemotherapy. 2012;58(2):146-51. doi: 10.1159/000337076. Epub 2012 May 12.

PMID:
22584412
3.
4.

Time-kill studies with micafungin and voriconazole against Candida glabrata intracellularly in human monocyte-derived macrophages and extracellularly in broth.

Baltch AL, Ritz W, Bopp LH, Michelsen PB, Smith RP.

Diagn Microbiol Infect Dis. 2011 Aug;70(4):468-74. doi: 10.1016/j.diagmicrobio.2011.04.008.

PMID:
21767703
5.
6.

Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis.

Smith RP, Baltch A, Bopp LH, Ritz WJ, Michelsen PP.

Diagn Microbiol Infect Dis. 2011 Oct;71(2):131-8. doi: 10.1016/j.diagmicrobio.2011.06.018. Epub 2011 Aug 23.

PMID:
21865002
7.
8.

The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation.

Seider K, Brunke S, Schild L, Jablonowski N, Wilson D, Majer O, Barz D, Haas A, Kuchler K, Schaller M, Hube B.

J Immunol. 2011 Sep 15;187(6):3072-86. doi: 10.4049/jimmunol.1003730. Epub 2011 Aug 17.

9.

Combined antifungal therapy in a murine infection by Candida glabrata.

Mariné M, Serena C, Pastor FJ, Guarro J.

J Antimicrob Chemother. 2006 Dec;58(6):1295-8. Epub 2006 Sep 29.

PMID:
17012301
10.

Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.

Shorr AF, Wu C, Kothari S.

J Antimicrob Chemother. 2011 Feb;66(2):375-80. doi: 10.1093/jac/dkq446. Epub 2010 Dec 8.

PMID:
21147825
11.

Antifungal susceptibility testing of micafungin against Candida glabrata isolates.

Oliveira ER, Fothergill A, Kirkpatrick WR, Patterson TF, Redding SW.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Apr;105(4):457-9. doi: 10.1016/j.tripleo.2007.12.003.

PMID:
18329581
12.

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).

Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M.

Int J Antimicrob Agents. 2011 Jul;38(1):65-9. doi: 10.1016/j.ijantimicag.2011.02.016. Epub 2011 Apr 22.

PMID:
21514797
14.

Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?

Meléndez J, García V, Sánchez E, Delgado R, Torres G, Meléndez-Guerrero LM.

Cell Mol Biol (Noisy-le-grand). 2001;47 Online Pub:OL51-9.

PMID:
11936874
15.

Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.

Miranda-Zapico I, Eraso E, Hernández-Almaraz JL, López-Soria LM, Carrillo-Muñoz AJ, Hernández-Molina JM, Quindós G.

J Antimicrob Chemother. 2011 Oct;66(10):2315-22. doi: 10.1093/jac/dkr298. Epub 2011 Jul 26.

PMID:
21795259
16.

Activation, cytokine production, and intracellular survival of bacteria in Salmonella-infected human monocyte-derived macrophages and dendritic cells.

Pietilä TE, Veckman V, Kyllönen P, Lähteenmäki K, Korhonen TK, Julkunen I.

J Leukoc Biol. 2005 Oct;78(4):909-20. Epub 2005 Jul 20.

PMID:
16033811
17.

Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages.

Bopp LH, Baltch AL, Ritz WJ, Michelsen PB, Smith RP.

J Med Microbiol. 2006 Jul;55(Pt 7):865-70.

PMID:
16772413
18.

Intracellular survival of Candida glabrata in macrophages: immune evasion and persistence.

Kasper L, Seider K, Hube B.

FEMS Yeast Res. 2015 Aug;15(5):fov042. doi: 10.1093/femsyr/fov042. Epub 2015 Jun 10. Review.

PMID:
26066553
19.

Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.

Mariné M, Serena C, Fernández-Torres B, Pastor FJ, Guarro J.

Antimicrob Agents Chemother. 2005 Nov;49(11):4757-9.

20.

New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.

Fera MT, La Camera E, De Sarro A.

Expert Rev Anti Infect Ther. 2009 Oct;7(8):981-98. doi: 10.1586/eri.09.67. Review.

PMID:
19803707

Supplemental Content

Support Center